| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in NTRA over the last quarter tilts toward selling: insiders offloaded a net 300,318 shares worth roughly $107.1M. In the past 30 days, 0 insiders bought and 7 sold.
All 7 insiders who sold still hold shares after their sales.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 2.12M | $819.77M | -51,718 | |
| Dir | 217.7K | $84.27M | -5,128 | |
| Pres | 195.6K | $75.71M | -1,679 | |
| Other | 168.2K | $65.12M | -1,852 | |
| Pres | 104.7K | $40.55M | -2,172 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 28, 2024 | Steven Leonard Chapman53 | CEO and President | Sell10b5-1 | 3,960 | $118.21 | $468,113.58 | -2.0% | +36.9% | +57.0% | |
| Oct 28, 2024 | John Fesko | President, Chief Bus. Officer | Sell10b5-1 | 929 | $118.21 | $109,817.55 | -0.8% | +36.9% | +57.0% | |
| Oct 28, 2024 | Solomon Moshkevich | President, Clinicaldiagnostics | Sell10b5-1 | 1,196 | $118.21 | $141,379.76 | -1.1% | +36.9% | +57.0% | |
| Oct 28, 2024 | Daniel Rabinowitz46 | Sec. and Chief Legal Officer | Sell10b5-1 | 1,057 | $118.21 | $124,948.50 | -0.5% | +36.9% | +57.0% | |
| Oct 25, 2024 | Michael Burkes Brophy46 | Chief Financial Officer | Sell10b5-1 | 1,605 | $119.03 | $191,037.37 | -2.2% | +46.0% | +63.6% | |
| Oct 23, 2024 | Michael Burkes Brophy46 | Chief Financial Officer | Sale+OE10b5-1 | 496 | $119.09 | $59,068.49 | -0.7% | +41.1% | +64.3% | |
| Oct 22, 2024 | John Fesko | President, Chief Bus. Officer | Sell10b5-1 | 541 | $120.50 | $65,192.89 | -0.5% | +39.6% | +56.7% | |
| Oct 22, 2024 | Solomon Moshkevich | President, Clinicaldiagnostics | Sell10b5-1 | 550 | $120.44 | $66,241.10 | -0.5% | +39.6% | +56.7% | |
| Oct 22, 2024 | Michael Burkes Brophy46 | Chief Financial Officer | Sale+OE10b5-1 | 1,062 | $120.46 | $127,932.28 | -1.4% | +39.6% | +56.7% | |
| Oct 22, 2024 | Steven Leonard Chapman53 | CEO and President | Sale+OE10b5-1 | 2,602 | $120.52 | $313,597.08 | -1.3% | +39.6% | +56.7% |